table of content
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Chronic Urticaria Or Hives Drug
1.2 Key Market Segments
1.2.1 Chronic Urticaria Or Hives Drug Segment by Type
1.2.2 Chronic Urticaria Or Hives Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Chronic Urticaria Or Hives Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Chronic Urticaria Or Hives Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Chronic Urticaria Or Hives Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Chronic Urticaria Or Hives Drug Market Competitive Landscape
3.1 Global Chronic Urticaria Or Hives Drug Sales by Manufacturers (2019-2024)
3.2 Global Chronic Urticaria Or Hives Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Chronic Urticaria Or Hives Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Chronic Urticaria Or Hives Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Chronic Urticaria Or Hives Drug Sales Sites, Area Served, Product Type
3.6 Chronic Urticaria Or Hives Drug Market Competitive Situation and Trends
3.6.1 Chronic Urticaria Or Hives Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Chronic Urticaria Or Hives Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Chronic Urticaria Or Hives Drug Industry Chain Analysis
4.1 Chronic Urticaria Or Hives Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Chronic Urticaria Or Hives Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Chronic Urticaria Or Hives Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Chronic Urticaria Or Hives Drug Sales Market Share by Type (2019-2024)
6.3 Global Chronic Urticaria Or Hives Drug Market Size Market Share by Type (2019-2024)
6.4 Global Chronic Urticaria Or Hives Drug Price by Type (2019-2024)
7 Chronic Urticaria Or Hives Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Chronic Urticaria Or Hives Drug Market Sales by Application (2019-2024)
7.3 Global Chronic Urticaria Or Hives Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Chronic Urticaria Or Hives Drug Sales Growth Rate by Application (2019-2024)
8 Chronic Urticaria Or Hives Drug Market Segmentation by Region
8.1 Global Chronic Urticaria Or Hives Drug Sales by Region
8.1.1 Global Chronic Urticaria Or Hives Drug Sales by Region
8.1.2 Global Chronic Urticaria Or Hives Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Chronic Urticaria Or Hives Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Chronic Urticaria Or Hives Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Chronic Urticaria Or Hives Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Chronic Urticaria Or Hives Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 AstraZeneca Plc
9.1.1 AstraZeneca Plc Chronic Urticaria Or Hives Drug Basic Information
9.1.2 AstraZeneca Plc Chronic Urticaria Or Hives Drug Product Overview
9.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Product Market Performance
9.1.4 AstraZeneca Plc Business Overview
9.1.5 AstraZeneca Plc Chronic Urticaria Or Hives Drug SWOT Analysis
9.1.6 AstraZeneca Plc Recent Developments
9.2 Biofrontera AG
9.2.1 Biofrontera AG Chronic Urticaria Or Hives Drug Basic Information
9.2.2 Biofrontera AG Chronic Urticaria Or Hives Drug Product Overview
9.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Product Market Performance
9.2.4 Biofrontera AG Business Overview
9.2.5 Biofrontera AG Chronic Urticaria Or Hives Drug SWOT Analysis
9.2.6 Biofrontera AG Recent Developments
9.3 ELORAC, Inc.
9.3.1 ELORAC, Inc. Chronic Urticaria Or Hives Drug Basic Information
9.3.2 ELORAC, Inc. Chronic Urticaria Or Hives Drug Product Overview
9.3.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Product Market Performance
9.3.4 ELORAC, Inc. Chronic Urticaria Or Hives Drug SWOT Analysis
9.3.5 ELORAC, Inc. Business Overview
9.3.6 ELORAC, Inc. Recent Developments
9.4 Faes Farma, SA
9.4.1 Faes Farma, SA Chronic Urticaria Or Hives Drug Basic Information
9.4.2 Faes Farma, SA Chronic Urticaria Or Hives Drug Product Overview
9.4.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Product Market Performance
9.4.4 Faes Farma, SA Business Overview
9.4.5 Faes Farma, SA Recent Developments
9.5 Genentech, Inc.
9.5.1 Genentech, Inc. Chronic Urticaria Or Hives Drug Basic Information
9.5.2 Genentech, Inc. Chronic Urticaria Or Hives Drug Product Overview
9.5.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Product Market Performance
9.5.4 Genentech, Inc. Business Overview
9.5.5 Genentech, Inc. Recent Developments
9.6 GlaxoSmithKline Plc
9.6.1 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Basic Information
9.6.2 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product Overview
9.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product Market Performance
9.6.4 GlaxoSmithKline Plc Business Overview
9.6.5 GlaxoSmithKline Plc Recent Developments
9.7 J Uriach Y Compania, S.A.
9.7.1 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Basic Information
9.7.2 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product Overview
9.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product Market Performance
9.7.4 J Uriach Y Compania, S.A. Business Overview
9.7.5 J Uriach Y Compania, S.A. Recent Developments
9.8 Mabtech Limited
9.8.1 Mabtech Limited Chronic Urticaria Or Hives Drug Basic Information
9.8.2 Mabtech Limited Chronic Urticaria Or Hives Drug Product Overview
9.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Product Market Performance
9.8.4 Mabtech Limited Business Overview
9.8.5 Mabtech Limited Recent Developments
9.9 Merck and Co., Inc.
9.9.1 Merck and Co., Inc. Chronic Urticaria Or Hives Drug Basic Information
9.9.2 Merck and Co., Inc. Chronic Urticaria Or Hives Drug Product Overview
9.9.3 Merck and Co., Inc. Chronic Urticaria Or Hives Drug Product Market Performance
9.9.4 Merck and Co., Inc. Business Overview
9.9.5 Merck and Co., Inc. Recent Developments
9.10 Mycenax Biotech Inc.
9.10.1 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Basic Information
9.10.2 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product Overview
9.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product Market Performance
9.10.4 Mycenax Biotech Inc. Business Overview
9.10.5 Mycenax Biotech Inc. Recent Developments
9.11 Novartis AG
9.11.1 Novartis AG Chronic Urticaria Or Hives Drug Basic Information
9.11.2 Novartis AG Chronic Urticaria Or Hives Drug Product Overview
9.11.3 Novartis AG Chronic Urticaria Or Hives Drug Product Market Performance
9.11.4 Novartis AG Business Overview
9.11.5 Novartis AG Recent Developments
9.12 Panacea Biotec Limited
9.12.1 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Basic Information
9.12.2 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product Overview
9.12.3 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product Market Performance
9.12.4 Panacea Biotec Limited Business Overview
9.12.5 Panacea Biotec Limited Recent Developments
10 Chronic Urticaria Or Hives Drug Market Forecast by Region
10.1 Global Chronic Urticaria Or Hives Drug Market Size Forecast
10.2 Global Chronic Urticaria Or Hives Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Chronic Urticaria Or Hives Drug Market Size Forecast by Country
10.2.3 Asia Pacific Chronic Urticaria Or Hives Drug Market Size Forecast by Region
10.2.4 South America Chronic Urticaria Or Hives Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Chronic Urticaria Or Hives Drug by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Chronic Urticaria Or Hives Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Chronic Urticaria Or Hives Drug by Type (2025-2030)
11.1.2 Global Chronic Urticaria Or Hives Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Chronic Urticaria Or Hives Drug by Type (2025-2030)
11.2 Global Chronic Urticaria Or Hives Drug Market Forecast by Application (2025-2030)
11.2.1 Global Chronic Urticaria Or Hives Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Chronic Urticaria Or Hives Drug Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
